Paragon
Tirzepatide 30MG
Tirzepatide 30MG
Couldn't load pickup availability
⚠️ PAYMENT METHOD: PayID or Bank Transfer Only
After checkout, you must complete payment manually.
Tirzepatide is a GLP-2 agonist, meaning it aids with appetite suppression and increased insulin sensitivity. It has widely been noted that Tirzepatide has a stronger appetite suppression effect than its cousin Retatrutide.
For best results, both of them may be stacked together.
This product is supplied strictly for research and laboratory use only and is not intended for human or veterinary application.
Key Research Notes
- Referenced in experimental models investigating metabolic regulation and body weight
- Studied for its interaction with GLP-1 and GIP receptor signalling pathways
- Widely used in laboratory research exploring energy balance and metabolic function
- Provided in a stable, lyophilised form suitable for long-term storage and analytical consistency
Product Information
- Compound: Tirzepatide
- Form: Lyophilised powder
- Purity: Independently tested (COA available)
- Handling: Reconstitution and storage should follow standard laboratory protocols
Quality & Testing
All Paragon compounds undergo third-party analytical testing to verify purity, identity, and consistency. Certificates of Analysis (COAs) are available for transparency and quality assurance.
Important Notice
This compound is sold exclusively for research purposes.
Not approved for human consumption, injection, or therapeutic use.
Purchasers must be 18 years or older and acknowledge responsibility for proper laboratory handling.
Share
